ABSTRACT
Objective:To explore the effect of supportive-expressive therapy (SET) on fear of progression and resilience in lymphoma patients, to provide reference for clinical nursing care.Methods:A total of 86 patients with lymphoma treated in the First Affiliated Hospital of Nanjing Medical University from February 2019 to September 2020 were divided into experimental group and control group according to random number table method, with 43 cases in each group. The control group was given conventional nursing, while the experimental group was applied with 6 times SET. Before and after intervention, the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) and Connor Davidson Resilience Scale (CD-RISC) was evaluated between two groups.Results:Finally, 40 cases were included in the experimental group and 42 cases in the control group. There was no significant difference between each dimension and total score of the two groups before intervention ( P>0.05). After intervention, scores of physiological health dimension, social and family dimension, and total FoP-Q-SF were (14.90 ± 3.96) points, (15.03 ± 4.29) points and (29.93 ± 5.65) points in the experimental group, significantly lower than those in the control group (17.71 ± 3.38) points, (17.29 ± 4.03) points and (35.00 ± 5.57) points ( t=3.47, 2.46, 4.10, all P<0.05); scores of tenacity, strength, optimism dimension and total CD-RISC were (28.08 ± 4.47) points, (21.30 ± 5.58) points, (10.65 ± 2.97) points and (60.03 ± 8.42) points in the experimental group, significantly higher than those in the control group (24.31 ± 4.11) points, (17.98 ± 4.13) points, (9.26 ± 2.47) points and (51.55 ± 5.86) points, the differences were statistically significant ( t values were 2.30-5.27, all P<0.05). Conclusions:SET can effectively alleviate the degree of fear of progression and promote resilience of lymphoma patients.
ABSTRACT
Objective:To explore the impact of supportive-expressive group therapy on the fear of disease progression and self-perceived burden of patients with early chronic kidney disease (CKD).Methods:A total of 150 early CKD patients in the Nephrology Department of Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine from May 2018 to July 2020 were selected and divided into research group with 88 cases and control group with 88 cases by random number table method. There were 12 cases were lost in the research group, 14 cases were lost in the control group. 76 cases in the research group and 74 cases in the control group were involved in the statistical analysis. The control group was treated with routine nursing while the research group was treated with nursing measures based on supportive-expressive group therapy as well as routine nursing. The effect of intervention was assessed by Fear of disease Progression (FoP) Questionnaire and Self-Perceived Burden Scale (SPBS) before and 12 weeks after the intervention.Results:There was no significant difference in the scores of FoP and Self Perceived Burden Scale (SPBS) between the two groups before the intervention ( P>0.05). After intervention, the scores of emotional reactions, loss of autonomy, partnership/family, anxiety response and the total score of FoP in the research group were (35.79 ± 5.82), (18.52 ± 3.16), (16.23 ± 2.27), (21.57 ± 2.92), (110.81 ± 17.12) respectively, which were lower than those in the control group (47.61 ± 7.13), (24.61 ± 3.97), (24.52 ± 3.71), (31.67 ± 3.87), (147.32 ± 21.72), and the differences were statistically significant ( t values were -18.07 - -10.41, all P<0.05). After intervention, the scores of physical factors, emotional factors and the total score of SPBS in the research group were (10.15 ± 1.82), (10.17 ± 1.86), (24.01 ± 4.25), which were lower than those in the control group (15.87 ± 2.57), (16.81 ± 3.14), (36.39 ± 6.32), and the differences were statistically significant ( t values were -15.76, -15.92, -14.11, all P<0.05). Conclusions:Supportive-expressive group therapy can effectively reduce the early CKD patients′ fear of disease progression and relieve their self-perceived burden.
ABSTRACT
Background: Inflammatory bowel disease (IBD) is a recurrent disease with unknown etiology. Psychological disorders such as anxiety, depression and fear are commonly seen in IBD patients and seriously reduce the quality of life. Aims: To investigate the current status of fear of progression in patients with IBD and its relationship with the quality of life. Methods: IBD patients admitted to the Department of Gastroenterology, Xijing Hospital, Air Force Medical University from October 2020 to December 2020 were enrolled consecutively. The demographic data and clinical data on disease course and severity were collected. A questionnaire survey was conducted by using Fear of Progression Questionnaire-Short Form (FoP-Q-SF) and the MOS 36-Item Short-Form Health Survey (SF-36). Results: A total of 225 IBD patients were enrolled, including 146 cases of ulcerative colitis (UC) and 79 cases of Crohn's disease (CD). The mean score of FoP-Q-SF was 34.89±9.70. Using 34 points as the cut-off value, 53.3% of the IBD patients were identified as fear of progression. The FoP-Q-SF score in CD patients was significantly higher than that in UC patients (36.92±10.47 vs. 33.80±9.11, P<0.05). Fear of progression was positively correlated with the disease activity and severity in both UC and CD patients (all P<0.05), whereas age was negatively correlated with fear of progression (P<0.05). In patients with FoP-Q-SF score equal or greater than 34 points, scores of 5 health concepts of SF-36 scale, including physical functioning, role-physical, role-emotional, mental health, and general health were significantly lower than those with FoP-Q-SF score less than 34 points (all P<0.05). In addition, the quality of life was also affected by age, education level and length of disease course. Conclusions: Fear of progression is prevalent in IBD patients and may affect the quality of life, and is correlated with disease type (UC/CD), age and activity and severity of the disease.
ABSTRACT
@#Introduction: Fear of cancer progression may lead to worsening of psychological complications of cancer and affects the quality of life of cancer patients. Hence, fear of cancer progression needs to be monitored. This study translated the original English version of the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) into the Malay language and investigated the reliability and validity of the Malay version of the FoP-Q-SF (FoP-Q-SF-M) among Malaysian cancer patients. Methods: Concurrent translation and back translation of the English version of the FoP-Q-SF to the FoP-Q-SF-M was performed, and the FoP-Q-SF-M and the Malay version of the Cancer Therapy Satisfaction Questionnaire (CTSQ-M) (as a comparison to assess the discriminant validity of the FoP-Q-SF-M) were administered to 200 cancer patients with different sites, stages, and duration of cancer diagnosis. Results: The CTSQ-M exhibited excellent internal consistency (Cronbach’s α= 0.927) as well as demonstrated good convergent and discriminant validity. Exploratory factor analysis of the FoP-Q-SF-M extracted one factor with twelfth items, thereby this supports the single-factor model reported by the English version of the FoP-Q-SF. Conclusion: The FoP-Q-SF-M exhibited acceptable psychometric properties and valid for use to assess fear of cancer progression in the Malaysian cancer population.